Comorbidities and Co-Medications in Populations With and Without Chronic Hepatitis C Virus Infection in Japan Between 2015 and 2016

BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-018-3148-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Co-Infection With Hepatitis C Virus and Human T Lymphocyte Virus

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2007English

Hepatitis C Virus and HIV Type 1 Co-Infection

Infectious Disease Reports
Infectious Diseases
2013English

Relationship Between Hepatitis B Virus Infection and Chronic Kidney Disease in Asian Populations: A Meta-Analysis

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2016English

The Distribution of Hepatitis C Virus Genotypes in Patients With Chronic Hepatitis C Infection

Türk Mikrobiyoloji Cemiyeti Dergisi
2016English

Serum Markers for Assessing Liver Fibrosis in Egyptian Patients With Chronic Hepatitis B and C Co-Infection Versus Chronic Hepatitis C

Journal of the Egyptian Society of Parasitology
2016English

Epidemiology and Long Term Prognosis of Hepatitis C Virus Infection in Japan.

Gut
Gastroenterology
1993English

Autoimmunity and Extrahepatic Manifestations in Treatment-Naïve Children With Chronic Hepatitis C Virus Infection

Clinical and Developmental Immunology
2012English

Risk Factors for Hepatitis C Virus Infection in Canadian Patients With Chronic Type C Hepatitis

Canadian Journal of Gastroenterology
1995English

Editorial: Comorbidities, Concomitant Medications, and Potential Drug-Drug Interactions With Interferon-Free Direct-Acting Anti-Viral Agents in Chronic Hepatitis C

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy